Hain Celestial Reports Fourth Quarter and Fiscal Year 2020 Financial Results
FINANCIAL HIGHLIGHTS1
Summary of Fourth Quarter Results from Continuing Operations2
- Net sales increased 1% to
$511.7 million , or 3% on a constant currency basis, compared to the prior year period. - When adjusted for Foreign Exchange, Divestitures, discontinued brands and Stock Keeping Unit ("SKU") rationalization3, net sales increased 7% compared to the prior year period.
- Gross margin of 25.4%, a 658 basis point increase from the prior year period.
- Adjusted gross margin of 25.3%, a 257 basis point increase from the prior year period.
- Operating income of
$25.3 million compared to an operating loss of$2.6 million in the prior year period. - Adjusted operating income of
$47.9 million compared to$34.4 million in the prior year period. - Net income of
$3.7 million compared to a net loss of$7.3 million in the prior year period. - Adjusted net income of
$32.3 million compared to$19.9 million in prior year period. - Adjusted EBITDA of
$62.2 million compared to$49.4 million in the prior year period. - Adjusted EBITDA margin of 12.1%, a 237 basis point increase compared to the prior year period.
- Earnings per diluted share ("EPS") of
$0.04 compared to a loss of$0.07 in the prior year period. - Adjusted EPS of
$0.32 compared to$0.19 in the prior year period. - Repurchased 0.1 million shares, or 0.1% of the outstanding common stock, at an average price of
$24.97 per share. - Net cash provided by continuing operations of
$92.8 million compared to$21.0 million in prior year period. - Operating free cash flow4 from continuing operations of
$78.9 million compared to$0.3 million in prior year period.
Summary of Fiscal Year 2020 Results from Continuing Operations2
- Net sales decreased 2% to
$2,053.9 million compared to the prior year. - Net sales decreased 1% on a constant currency basis compared to the prior year.
- When adjusted for Foreign Exchange, Divestitures, discontinued brands and "SKU" rationalization3, net sales increased 3% compared to the prior year.
- Gross margin of 22.7%, a 374 basis point increase over the prior year.
- Adjusted gross margin of 23.2%, a 257 basis point increase over the prior year.
- Operating income of
$56.0 million compared to operating loss of$32.5 million in the prior year. - Adjusted operating income of
$140.0 million compared to$109.9 million in the prior year. - Net income of
$25.6 million compared to net loss of$53.4 million in the prior year. - Adjusted net income of
$87.1 million compared to$62.1 million in prior year. - Adjusted EBITDA of
$200.0 million compared to$165.1 million in the prior year. - Adjusted EBITDA margin of 9.7%, a 189 basis point increase compared to the prior year.
- EPS of
$0.25 compared to a loss of$0.51 in the prior year. - Adjusted EPS of
$0.84 compared to$0.60 in the prior year. - Repurchased 2.6 million shares, or 2.4% of the outstanding common stock, at an average price of
$23.59 per share. - Net cash provided by continuing operations of
$156.9 million compared to$39.3 million in prior year. - Operating free cash flow4 from continuing operations of
$96.0 million compared to negative operating free cash flow of$36.4 million in prior year.
SEGMENT HIGHLIGHTS FROM CONTINUING OPERATIONS
Historically, the Company had three reportable segments:
Segment gross profit in the fourth quarter was
Segment operating income in the fourth quarter was
Adjusted EBITDA in the fourth quarter was
Segment gross profit in fiscal year 2020 was
Segment operating income in fiscal year 2020 was
Adjusted EBITDA in fiscal year 2020 was
International
International net sales in the fourth quarter were
Segment gross profit in the fourth quarter was
Segment operating income in the fourth quarter was
Adjusted EBITDA in the fourth quarter was
International net sales in fiscal year 2020 were
Segment gross profit in fiscal year 2020 was
Segment operating income in fiscal year 2020 was
Adjusted EBITDA in fiscal year 2020 was
1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided herein in the tables "Reconciliation of GAAP Results to Non-GAAP Measures."
2 Unless otherwise noted all results included in this press release are from continuing operations.
3 Refer to "Net Sales Growth at Constant Currency" and "Adjusted for Divestitures, discontinued brands and SKU Rationalization" provided herein.
4 Refer to Non-GAAP Financial Measures below for definition of operating free cash flow from continuing operations.
CAPITAL MANAGEMENT
During fiscal year 2020, the Company repurchased 2.6 million shares, or 2.4% of the outstanding common stock, at an average price of
SALE OF RUDI'S BAKERY
Effective
SALE OF DANIVAL
Effective
FISCAL YEAR 2021 GUIDANCE
Due to the uncertainty around the duration and impact of the COVID-19 pandemic, the Company is not providing specific financial guidance for fiscal 2021. For fiscal 2021, the Company expects continued margin expansion, strong double digit adjusted EBITDA growth and double digit operating free cash flow growth. The Company believes that the first half of fiscal 2021 will yield stronger net sales and adjusted EBITDA growth than the second half of the year due to its strong consumer and customer plans as well as increased at home eating occasions related to COVID-19. For the first quarter, based on actual results to date, the Company expects mid-single digit net sales growth after adjusting for divestitures and discontinued brands, and several hundred basis points of margin improvement and adjusted EBITDA growth.
Webcast Presentation
About
Safe Harbor Statement
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future events and are not statements of historical fact. You can identify forward-looking statements by the use of forward-looking terminology such as "plan", "continue", "expect", "anticipate", "intend", "predict", "project", "estimate", "likely", "believe", "might", "seek", "may", "will", "remain", "potential", "can", "should", "could", "future" and similar expressions, or the negative of those expressions, or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of the Company's strategic initiatives, including productivity and transformation, the Company's guidance for fiscal year 2021 and our future performance and results of operations.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, levels of activity, performance or achievements of the Company, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements, and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). Such factors include, among others, challenges and uncertainty resulting from the COVID-19 pandemic, the impact of competitive products and changes to the competitive environment, changes to consumer preferences, general economic and financial market conditions, the
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including net sales adjusted for the impact of Foreign Exchange, Divestitures, discontinued brands and certain other items, including SKU rationalization, as applicable in each case, adjusted operating income and its related margin, adjusted gross margin, adjusted net income, adjusted earnings per diluted share, Adjusted EBITDA and its related margin and operating free cash flow. The reconciliations of these non-GAAP financial measures to the comparable GAAP financial measures are presented in the tables "Reconciliation of GAAP Results to Non-GAAP Measures" for the three and twelve months ended
The Company defines Operating Free Cash Flow as cash provided by or used in operating activities from continuing operations (a GAAP measure) less capital expenditures. The Company views Operating Free Cash Flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments.
For the three and twelve months ended
Three Months Ended |
Twelve Months Ended |
|||||||
2020 |
2019 |
2020 |
2019 |
|||||
(unaudited and in thousands) |
||||||||
Cash flow provided by operating activities from continuing operations |
$ 92,822 |
$ 21,001 |
$ 156,914 |
$ 39,333 |
||||
Purchases of property, plant and equipment |
(13,932) |
(20,719) |
(60,893) |
(75,792) |
||||
Operating Free Cash Flow from continuing operations |
$ 78,890 |
$ 282 |
$ 96,021 |
$ (36,459) |
The Company's Operating Free Cash Flow from continuing operations was
The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company's consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the
The Company provides net sales adjusted for constant currency, divestitures, discontinued brands, and certain other items including SKU rationalization, as applicable in each case, to understand the growth rate of net sales excluding the impact of such items. The Company's management believes net sales adjusted for such items is useful to investors because it enables them to better understand the growth of our business from period-to-period.
The Company defines Adjusted EBITDA as net income (loss) before income taxes, net interest expense, depreciation and amortization, impairment of long-lived and intangible assets, equity in net loss of equity-method investees, stock-based compensation, net, stock-based compensation expense in connection with the Company's former CEO Succession Plan, Productivity and transformation costs, SKU rationalization and certain inventory write-downs, unrealized currency gains and losses and other adjustments. The Company's management believes that these presentations provide useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses these measures for reviewing the financial results of the Company as well as a component of performance-based executive compensation.
For the three and twelve months ended
Three Months Ended |
Twelve Months Ended |
||||||
2020 |
2019 |
2020 |
2019 |
||||
(unaudited and in thousands) |
|||||||
Net income (loss) |
$ 3,239 |
$ (13,551) |
$ (80,407) |
$ (183,314) |
|||
Net loss from discontinued operations |
(460) |
(6,215) |
(106,041) |
(129,887) |
|||
Net income (loss) from continuing operations |
$ 3,699 |
$ (7,336) |
$ 25,634 |
$ (53,427) |
|||
Provision (benefit) for income taxes |
15,958 |
(1,306) |
6,205 |
(3,232) |
|||
Interest expense, net |
2,467 |
5,484 |
14,351 |
19,450 |
|||
Depreciation and amortization |
12,019 |
13,350 |
52,088 |
50,898 |
|||
Equity in net loss of equity-method investees |
770 |
264 |
1,989 |
655 |
|||
Stock-based compensation, net |
3,497 |
3,982 |
13,078 |
9,471 |
|||
Stock-based compensation expense in connection with Former Chief Executive Officer Succession Plan |
- |
- |
- |
429 |
|||
|
394 |
- |
394 |
- |
|||
Long-lived asset and intangibles impairment |
12,079 |
10,010 |
27,493 |
33,719 |
|||
Unrealized currency losses (gains) |
355 |
(3,401) |
543 |
(850) |
|||
Productivity and transformation costs |
10,194 |
10,494 |
47,596 |
39,958 |
|||
Former Chief Executive Officer Succession Plan expense, net |
- |
- |
- |
29,727 |
|||
Proceeds from insurance claim |
- |
(4,460) |
(2,962) |
(4,460) |
|||
Accounting review and remediation costs, net of insurance proceeds |
- |
- |
- |
4,334 |
|||
Loss (gain) on sale of business |
1,448 |
(534) |
3,564 |
(534) |
|||
Warehouse/manufacturing facility start-up costs |
385 |
8,107 |
3,440 |
17,636 |
|||
Plant closure related costs |
3 |
1,232 |
2,357 |
4,734 |
|||
SKU rationalization and inventory write-down |
(1,103) |
10,346 |
4,175 |
12,381 |
|||
Litigation and related expenses |
- |
455 |
48 |
1,517 |
|||
Realized currency loss on repayment of international loans |
- |
2,706 |
- |
2,706 |
|||
Adjusted EBITDA |
$ 62,165 |
$ 49,393 |
$ 199,993 |
$ 165,112 |
|
||||
|
||||
(unaudited and in thousands) |
||||
|
International |
Corporate/Other |
Total |
|
|
||||
Net sales - Three months ended |
$ 298,644 |
$ 213,102 |
$ - |
$ 511,746 |
Net sales - Three months ended |
$ 284,893 |
$ 220,412 |
$ - |
$ 505,305 |
% change - FY'20 net sales vs. FY'19 net sales |
4.8% |
(3.3)% |
1.3% |
|
Gross Profit |
||||
Three months ended |
||||
Gross profit |
$ 83,589 |
$ 46,348 |
$ - |
$ 129,937 |
Non-GAAP adjustments (1) |
(728) |
13 |
- |
(715) |
Adjusted gross profit |
$ 82,861 |
$ 46,361 |
$ - |
$ 129,222 |
Gross margin |
28.0% |
21.7% |
25.4% |
|
Adjusted gross margin |
27.7% |
21.8% |
25.3% |
|
Three months ended |
||||
Gross profit |
$ 50,659 |
$ 44,371 |
$ - |
$ 95,030 |
Non-GAAP adjustments (1) |
18,308 |
1,284 |
- |
19,592 |
Adjusted gross profit |
$ 68,967 |
$ 45,655 |
$ - |
$ 114,622 |
Gross margin |
17.8% |
20.1% |
18.8% |
|
Adjusted gross margin |
24.2% |
20.7% |
22.7% |
|
Operating income (loss) |
||||
Three months ended |
||||
Operating income (loss) |
$ 31,867 |
$ 14,667 |
$ (21,273) |
$ 25,261 |
Non-GAAP adjustments (1) |
7,020 |
8,056 |
7,521 |
22,597 |
Adjusted operating income (loss) |
$ 38,887 |
$ 22,723 |
$ (13,752) |
$ 47,858 |
Operating income margin |
10.7% |
6.9% |
4.9% |
|
Adjusted operating income margin |
13.0% |
10.7% |
9.4% |
|
Three months ended |
||||
Operating (loss) income |
$ (2,745) |
$ 18,112 |
$ (18,008) |
$ (2,641) |
Non-GAAP adjustments (1) |
27,500 |
4,878 |
4,706 |
37,084 |
Adjusted operating income (loss) |
$ 24,755 |
$ 22,990 |
$ (13,302) |
$ 34,443 |
Operating (loss) income margin |
(1.0)% |
8.2% |
(0.5)% |
|
Adjusted operating income margin |
8.7% |
10.4% |
6.8% |
|
(1) See accompanying table of "Reconciliation of GAAP Results to Non-GAAP Measures" |
|
||||
|
||||
(unaudited and in thousands) |
||||
|
International |
Corporate/Other |
Total |
|
|
||||
Net sales - Twelve months ended |
$ 1,171,478 |
$ 882,425 |
$ - |
$ 2,053,903 |
Net sales - Twelve months ended |
$ 1,195,979 |
$ 908,627 |
$ - |
$ 2,104,606 |
% change - FY'20 net sales vs. FY'19 net sales |
(2.0)% |
(2.9)% |
(2.4)% |
|
Gross Profit |
||||
Twelve months ended |
||||
Gross profit |
$ 293,545 |
$ 172,225 |
$ - |
$ 465,770 |
Non-GAAP adjustments (1) |
7,309 |
2,679 |
- |
9,988 |
Adjusted gross profit |
$ 300,854 |
$ 174,904 |
$ - |
$ 475,758 |
Gross margin |
25.1% |
19.5% |
22.7% |
|
Adjusted gross margin |
25.7% |
19.8% |
23.2% |
|
Twelve months ended |
||||
Gross profit |
$ 225,707 |
$ 172,790 |
$ - |
$ 398,497 |
Non-GAAP adjustments (1) |
30,952 |
3,948 |
- |
34,900 |
Adjusted gross profit |
$ 256,659 |
$ 176,738 |
$ - |
$ 433,397 |
Gross margin |
18.9% |
19.0% |
18.9% |
|
Adjusted gross margin |
21.5% |
19.5% |
20.6% |
|
Operating income (loss) |
||||
Twelve months ended |
||||
Operating income (loss) |
$ 95,934 |
$ 55,333 |
$ (95,225) |
$ 56,042 |
Non-GAAP adjustments (1) |
25,083 |
18,559 |
40,296 |
83,938 |
Adjusted operating income (loss) |
$ 121,017 |
$ 73,892 |
$ (54,929) |
$ 139,980 |
Operating income margin |
8.2% |
6.3% |
2.7% |
|
Adjusted operating income margin |
10.3% |
8.4% |
6.8% |
|
Twelve months ended |
||||
Operating income (loss) |
$ 32,682 |
$ 58,808 |
$ (123,983) |
$ (32,493) |
Non-GAAP adjustments (1) |
46,430 |
16,143 |
79,780 |
142,353 |
Adjusted operating income (loss) |
$ 79,112 |
$ 74,951 |
$ (44,203) |
$ 109,860 |
Operating income (loss) margin |
2.7% |
6.5% |
(1.5)% |
|
Adjusted operating income margin |
6.6% |
8.2% |
5.2% |
|
(1) See accompanying table of "Reconciliation of GAAP Results to Non-GAAP Measures" |
|
|||||
Consolidated Balance Sheets |
|||||
(unaudited and in thousands) |
|||||
June 30, |
June 30, |
||||
2020 |
2019 |
||||
ASSETS |
|||||
Current assets: |
|||||
Cash and cash equivalents |
$ 37,771 |
$ 31,017 |
|||
Accounts receivable, net |
170,969 |
209,990 |
|||
Inventories |
248,170 |
299,341 |
|||
Prepaid expenses and other current assets |
104,024 |
51,391 |
|||
Current assets of discontinued operations |
- |
110,048 |
|||
Total current assets |
560,934 |
701,787 |
|||
Property, plant and equipment, net |
289,256 |
287,845 |
|||
|
861,958 |
875,881 |
|||
Trademarks and other intangible assets, net |
346,462 |
380,286 |
|||
Investments and joint ventures |
17,439 |
18,890 |
|||
Operating lease right-of-use assets |
88,165 |
- |
|||
Other assets |
24,238 |
58,764 |
|||
Noncurrent assets of discontinued operations |
- |
259,167 |
|||
Total assets |
$ 2,188,452 |
$ 2,582,620 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||
Current liabilities: |
|||||
Accounts payable |
$ 171,009 |
$ 219,957 |
|||
Accrued expenses and other current liabilities |
127,612 |
114,265 |
|||
Current portion of long-term debt |
1,656 |
17,232 |
|||
Current liabilities of discontinued operations |
- |
31,703 |
|||
Total current liabilities |
300,277 |
383,157 |
|||
Long-term debt, less current portion |
281,118 |
613,537 |
|||
Deferred income taxes |
51,849 |
34,757 |
|||
Operating lease liabilities, noncurrent portion |
82,962 |
- |
|||
Other noncurrent liabilities |
28,692 |
14,489 |
|||
Noncurrent liabilities of discontinued operations |
- |
17,361 |
|||
Total liabilities |
744,898 |
1,063,301 |
|||
Stockholders' equity: |
|||||
Common stock |
1,092 |
1,088 |
|||
Additional paid-in capital |
1,171,875 |
1,158,257 |
|||
Retained earnings |
614,171 |
695,017 |
|||
Accumulated other comprehensive loss |
(171,392) |
(225,004) |
|||
1,615,746 |
1,629,358 |
||||
|
(172,192) |
(110,039) |
|||
Total stockholders' equity |
1,443,554 |
1,519,319 |
|||
Total liabilities and stockholders' equity |
$ 2,188,452 |
$ 2,582,620 |
|
|||||||
Consolidated Statements of Operations |
|||||||
(unaudited and in thousands, except per share amounts) |
|||||||
Three Months Ended |
Twelve Months Ended |
||||||
2020 |
2019 |
2020 |
2019 |
||||
Net sales |
$ 511,746 |
$ 505,305 |
$ 2,053,903 |
$ 2,104,606 |
|||
Cost of sales |
381,809 |
410,275 |
1,588,133 |
1,706,109 |
|||
Gross profit |
129,937 |
95,030 |
465,770 |
398,497 |
|||
Selling, general and administrative expenses |
79,171 |
78,439 |
324,376 |
314,000 |
|||
Amortization of acquired intangibles |
2,192 |
3,188 |
11,638 |
13,134 |
|||
Productivity and transformation costs |
10,840 |
10,494 |
48,789 |
40,107 |
|||
Former Chief Executive Officer Succession Plan expense, net |
- |
- |
- |
30,156 |
|||
Proceeds from insurance claim |
- |
(4,460) |
(2,962) |
(4,460) |
|||
Accounting review and remediation costs, net of insurance proceeds |
- |
- |
- |
4,334 |
|||
|
394 |
- |
394 |
- |
|||
Long-lived asset and intangibles impairment |
12,079 |
10,010 |
27,493 |
33,719 |
|||
Operating income (loss) |
25,261 |
(2,641) |
56,042 |
(32,493) |
|||
Interest and other financing expense, net |
3,190 |
6,781 |
18,258 |
22,517 |
|||
Other expense (income), net |
1,644 |
(1,044) |
3,956 |
994 |
|||
Income (loss) from continuing operations before income taxes and equity in net loss of equity-method investees |
20,427 |
(8,378) |
33,828 |
(56,004) |
|||
Provision (benefit) for income taxes |
15,958 |
(1,306) |
6,205 |
(3,232) |
|||
Equity in net loss of equity-method investees |
770 |
264 |
1,989 |
655 |
|||
Net income (loss) from continuing operations |
$ 3,699 |
$ (7,336) |
$ 25,634 |
$ (53,427) |
|||
Net loss from discontinued operations, net of tax |
(460) |
(6,215) |
(106,041) |
(129,887) |
|||
Net income (loss) |
$ 3,239 |
$ (13,551) |
$ (80,407) |
$ (183,314) |
|||
Net income (loss) per common share: |
|||||||
Basic net income (loss) per common share from continuing operations |
$ 0.04 |
$ (0.07) |
$ 0.25 |
$ (0.51) |
|||
Basic net loss per common share from discontinued operations |
(0.00) |
(0.06) |
(1.02) |
(1.25) |
|||
Basic net income (loss) per common share |
$ 0.04 |
$ (0.13) |
$ (0.77) |
$ (1.76) |
|||
Diluted net income (loss) per common share from continuing operations |
$ 0.04 |
$ (0.07) |
$ 0.25 |
$ (0.51) |
|||
Diluted net loss per common share from discontinued operations |
(0.00) |
(0.06) |
(1.02) |
(1.25) |
|||
Diluted net income (loss) per common share |
$ 0.04 |
$ (0.13) |
$ (0.77) |
$ (1.76) |
|||
Shares used in the calculation of net income (loss) per common share: |
|||||||
Basic |
101,895 |
104,167 |
103,618 |
104,076 |
|||
Diluted |
102,280 |
104,167 |
103,937 |
104,076 |
|
|||||||
Consolidated Statements of Cash Flows |
|||||||
(unaudited and in thousands) |
|||||||
Three Months Ended |
Twelve Months Ended |
||||||
2020 |
2019 |
2020 |
2019 |
||||
CASH FLOWS FROM OPERATING ACTIVITIES |
|||||||
Net income (loss) |
$ 3,239 |
$ (13,551) |
$ (80,407) |
$ (183,314) |
|||
Net loss from discontinued operations |
(460) |
(6,215) |
(106,041) |
(129,887) |
|||
Net income (loss) from continuing operations |
3,699 |
(7,336) |
25,634 |
(53,427) |
|||
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities from continuing operations: |
|||||||
Depreciation and amortization |
12,019 |
13,350 |
52,088 |
50,898 |
|||
Deferred income taxes |
45,195 |
818 |
36,160 |
(23,706) |
|||
Former Chief Executive Officer Succession Plan expense, net |
- |
(29,727) |
- |
- |
|||
Equity in net loss of equity-method investees |
770 |
264 |
1,989 |
655 |
|||
Stock-based compensation, net |
3,497 |
3,982 |
13,078 |
9,900 |
|||
|
394 |
- |
394 |
- |
|||
Long-lived asset and intangibles impairment |
12,079 |
10,010 |
27,493 |
33,719 |
|||
Other non-cash items, net |
1,571 |
(2,504) |
3,906 |
1,193 |
|||
Increase (decrease) in cash attributable to changes in operating assets and liabilities: |
|||||||
Accounts receivable |
64,726 |
31,124 |
33,856 |
26,658 |
|||
Inventories |
(14,044) |
18,920 |
33,236 |
30,550 |
|||
Other current assets |
(55,639) |
(6,992) |
(45,337) |
(7,215) |
|||
Other assets and liabilities |
7,152 |
(1,571) |
5,986 |
3,635 |
|||
Accounts payable and accrued expenses |
11,403 |
(9,337) |
(31,569) |
(33,527) |
|||
Net cash provided by operating activities from continuing operations |
92,822 |
21,001 |
156,914 |
39,333 |
|||
CASH FLOWS FROM INVESTING ACTIVITIES |
|||||||
Purchases of property and equipment |
(13,932) |
(20,719) |
(60,893) |
(75,792) |
|||
Proceeds from sale of businesses and other |
1,337 |
3,282 |
15,765 |
7,145 |
|||
Net cash used in investing activities from continuing operations |
(12,595) |
(17,437) |
(45,128) |
(68,647) |
|||
CASH FLOWS FROM FINANCING ACTIVITIES |
|||||||
Borrowings under bank revolving credit facility |
65,000 |
45,000 |
262,000 |
285,000 |
|||
Repayments under bank revolving credit facility |
(147,169) |
(82,000) |
(401,669) |
(268,791) |
|||
Repayments under term loan |
- |
(78,750) |
(206,250) |
(90,000) |
|||
Proceeds from discontinued operations entities |
398 |
90,458 |
305,645 |
56,643 |
|||
Repayments of other debt, net |
(538) |
(477) |
(2,040) |
(2,166) |
|||
Share repurchases |
(2,815) |
- |
(60,221) |
- |
|||
Shares withheld for payment of employee payroll taxes |
(425) |
(461) |
(1,931) |
(3,532) |
|||
Net cash used in financing activities from continuing operations |
(85,549) |
(26,230) |
(104,466) |
(22,846) |
|||
Effect of exchange rate changes on cash from continuing operations |
1,544 |
(748) |
(566) |
(1,522) |
|||
CASH FLOWS FROM DISCONTINUED OPERATIONS |
|||||||
Cash provided by (used in) operating activities |
398 |
15,563 |
(5,748) |
1,936 |
|||
Cash provided by investing activities |
- |
70,166 |
297,592 |
36,605 |
|||
Cash used in financing activities |
(398) |
(88,352) |
(299,816) |
(57,770) |
|||
Effect of exchange rate changes on cash from discontinued operations |
- |
(129) |
(537) |
(580) |
|||
Net cash flows used in discontinued operations |
- |
(2,752) |
(8,509) |
(19,809) |
|||
Net decrease in cash and cash equivalents |
(3,778) |
(26,166) |
(1,755) |
(73,491) |
|||
Cash and cash equivalents at beginning of period |
41,549 |
65,692 |
39,526 |
113,017 |
|||
Cash and cash equivalents at end of period |
$ 37,771 |
$ 39,526 |
$ 37,771 |
$ 39,526 |
|||
Less: cash and cash equivalents of discontinued operations |
- |
(8,509) |
- |
(8,509) |
|||
Cash and cash equivalents of continuing operations at end of period |
$ 37,771 |
$ 31,017 |
$ 37,771 |
$ 31,017 |
|
|||||||
Reconciliation of GAAP Results to Non-GAAP Measures |
|||||||
(unaudited and in thousands, except per share amounts) |
|||||||
Three Months Ended |
|||||||
2020 GAAP |
Adjustments |
2020 Adjusted |
2019 GAAP |
Adjustments |
2019 Adjusted |
||
Net sales |
$ 511,746 |
- |
511,746 |
$ 505,305 |
- |
$ 505,305 |
|
Cost of sales |
381,809 |
715 |
382,524 |
410,275 |
(19,591) |
390,684 |
|
Gross profit |
129,937 |
(715) |
129,222 |
95,030 |
19,591 |
114,622 |
|
Operating expenses (a) |
93,442 |
(12,079) |
81,363 |
91,637 |
(11,459) |
80,179 |
|
Productivity and transformation costs |
10,840 |
(10,840) |
- |
10,494 |
(10,494) |
- |
|
Proceeds from insurance claims |
- |
- |
- |
(4,460) |
4,460 |
- |
|
|
394 |
(394) |
- |
- |
- |
- |
|
Operating income (loss) |
25,261 |
22,597 |
47,858 |
(2,641) |
37,084 |
34,443 |
|
Interest and other expense (income), net (b) |
4,834 |
(1,803) |
3,031 |
5,737 |
882 |
6,619 |
|
Provision (benefit) provision for income taxes |
15,958 |
(4,243) |
11,715 |
(1,306) |
8,962 |
7,656 |
|
Net income (loss) from continuing operations |
3,699 |
28,644 |
32,343 |
(7,336) |
27,240 |
19,904 |
|
Net (loss) income from discontinued operations, net of tax |
(460) |
460 |
- |
(6,215) |
6,215 |
- |
|
Net income (loss) |
3,239 |
29,104 |
32,343 |
(13,551) |
33,455 |
19,904 |
|
Diluted net income (loss) per common share from continuing operations |
0.04 |
0.28 |
0.32 |
(0.07) |
0.26 |
0.19 |
|
Diluted net (loss) income per common share from discontinued operations |
(0.00) |
0.00 |
- |
(0.06) |
0.06 |
- |
|
Diluted net income (loss) per common share |
0.04 |
0.28 |
0.32 |
(0.13) |
0.32 |
0.19 |
|
Detail of Adjustments: |
|||||||
Three Months Ended |
Three Months Ended |
||||||
Warehouse/manufacturing facility start-up costs |
$ 385 |
$ 8,107 |
|||||
Plant closure related costs |
3 |
1,138 |
|||||
SKU rationalization and inventory write-down |
(1,103) |
10,346 |
|||||
Cost of sales |
(715) |
19,591 |
|||||
Gross profit |
(715) |
19,591 |
|||||
Long-lived asset impairment |
12,079 |
10,010 |
|||||
Stock-based compensation acceleration |
- |
875 |
|||||
Litigation and related expenses |
- |
455 |
|||||
Plant closure related costs |
- |
119 |
|||||
Operating expenses (a) |
12,079 |
11,459 |
|||||
Productivity and transformation costs |
10,840 |
10,494 |
|||||
Productivity and transformation costs |
10,840 |
10,494 |
|||||
Proceeds from insurance claims |
- |
(4,460) |
|||||
Proceeds from insurance claims |
- |
(4,460) |
|||||
|
394 |
- |
|||||
|
394 |
- |
|||||
Operating income (loss) |
22,597 |
37,084 |
|||||
Loss (gain) on sale of business |
1,448 |
(534) |
|||||
Unrealized currency losses (gains) |
355 |
(3,401) |
|||||
Realized currency loss on repayment of international loans |
- |
2,706 |
|||||
Deferred financing cost write-off |
- |
347 |
|||||
Interest and other expense (income), net (b) |
1,803 |
(882) |
|||||
Income tax related adjustments |
4,243 |
(8,962) |
|||||
Provision (benefit) provision for income taxes |
4,243 |
(8,962) |
|||||
Net income (loss) from continuing operations |
$ 28,644 |
$ 27,240 |
|||||
(a)Operating expenses include amortization of acquired intangibles, selling, general, and administrative expenses and long-lived asset impairment. |
|||||||
(b)Interest and other expense (income), net includes interest and other financing expenses, net and other expense, net. |
|
|||||||
Reconciliation of GAAP Results to Non-GAAP Measures |
|||||||
(unaudited and in thousands, except per share amounts) |
|||||||
Twelve Months Ended |
|||||||
2020 GAAP |
Adjustments |
2020 Adjusted |
2019 GAAP |
Adjustments |
2019 Adjusted |
||
Net sales |
$ 2,053,903 |
- |
$ 2,053,903 |
$ 2,104,606 |
- |
$ 2,104,606 |
|
Cost of sales |
1,588,133 |
(9,988) |
1,578,145 |
1,706,109 |
(34,900) |
1,671,209 |
|
Gross profit |
465,770 |
9,988 |
475,758 |
398,497 |
34,900 |
433,397 |
|
Operating expenses (a) |
363,507 |
(27,730) |
335,777 |
360,853 |
(37,316) |
323,537 |
|
Productivity and transformation costs |
48,789 |
(48,789) |
- |
40,107 |
(40,107) |
- |
|
Former Chief Executive Officer Succession Plan expense, net |
- |
- |
- |
30,156 |
(30,156) |
- |
|
Proceeds from insurance claim |
(2,962) |
2,962 |
- |
(4,460) |
4,460 |
- |
|
Accounting review and remediation costs, net of insurance proceeds |
- |
- |
- |
4,334 |
(4,334) |
- |
|
|
394 |
(394) |
- |
- |
- |
- |
|
Operating income (loss) |
56,042 |
83,938 |
139,980 |
(32,493) |
142,353 |
109,860 |
|
Interest and other expense (income), net (b) |
22,214 |
(5,082) |
17,132 |
23,511 |
(1,669) |
21,842 |
|
Provision (benefit) for income taxes |
6,205 |
27,575 |
33,780 |
(3,232) |
28,499 |
25,267 |
|
Net income (loss) from continuing operations |
25,634 |
61,445 |
87,079 |
(53,427) |
115,521 |
62,094 |
|
Net (loss) income from discontinued operations, net of tax |
(106,041) |
106,041 |
- |
(129,887) |
129,887 |
- |
|
Net (loss) income |
(80,407) |
167,486 |
87,079 |
(183,314) |
245,408 |
62,094 |
|
Diluted net income (loss) per common share from continuing operations |
0.25 |
0.59 |
0.84 |
(0.51) |
1.11 |
0.60 |
|
Diluted net (loss) income per common share from discontinued operations |
(1.02) |
1.02 |
- |
(1.25) |
1.25 |
- |
|
Diluted net (loss) income per common share |
(0.77) |
1.61 |
0.84 |
(1.76) |
2.36 |
0.60 |
|
Detail of Adjustments: |
|||||||
Twelve Months Ended |
Twelve Months Ended |
||||||
SKU rationalization and inventory write-down |
$ 4,175 |
$ 12,381 |
|||||
Warehouse/manufacturing facility start-up costs |
3,251 |
17,636 |
|||||
Plant closure related costs |
2,562 |
4,883 |
|||||
Cost of sales |
9,988 |
34,900 |
|||||
Gross profit |
9,988 |
34,900 |
|||||
Long-lived asset impairment |
17,954 |
15,819 |
|||||
Intangibles impairment |
9,539 |
17,900 |
|||||
Warehouse/manufacturing facility start-up costs |
189 |
- |
|||||
Litigation and related expenses |
48 |
1,517 |
|||||
Plant closure related costs |
- |
622 |
|||||
Stock-based compensation acceleration |
- |
1,458 |
|||||
Operating expenses (a) |
27,730 |
37,316 |
|||||
Productivity and transformation costs |
48,789 |
40,107 |
|||||
Productivity and transformation costs |
48,789 |
40,107 |
|||||
Former Chief Executive Officer Succession Plan expense, net |
- |
30,156 |
|||||
Former Chief Executive Officer Succession Plan expense, net |
- |
30,156 |
|||||
Proceeds from insurance claim |
(2,962) |
(4,460) |
|||||
Proceeds from insurance claim |
(2,962) |
(4,460) |
|||||
Accounting review and remediation costs, net of insurance proceeds |
- |
4,334 |
|||||
Accounting review and remediation costs, net of insurance proceeds |
- |
4,334 |
|||||
|
394 |
- |
|||||
|
394 |
- |
|||||
Operating income (loss) |
83,938 |
142,353 |
|||||
Loss (gain) on sale of business |
3,564 |
(534) |
|||||
Unrealized currency losses (gains) |
543 |
(850) |
|||||
Deferred financing cost write-off |
975 |
347 |
|||||
Realized currency loss on repayment of international loans |
- |
2,706 |
|||||
Interest and other expense (income), net (b) |
5,082 |
1,669 |
|||||
Income tax related adjustments |
(27,575) |
(28,499) |
|||||
Provision (benefit) for income taxes |
(27,575) |
(28,499) |
|||||
Net income (loss) from continuing operations |
$ 61,445 |
$ 115,523 |
|||||
(a)Operating expenses include amortization of acquired intangibles, selling, general, and administrative expenses and long-lived asset and intangibles impairment. |
|||||||
(b)Interest and other expense (income), net includes interest and other financing expenses, net and other expense, net. |
|
|||||
Net Sales Growth at Constant Currency |
|||||
(unaudited and in thousands) |
|||||
Hain |
|
International |
|||
Net sales - Three months ended 6/30/20 |
$ 511,746 |
$ 298,644 |
$ 213,102 |
||
Impact of foreign currency exchange |
8,192 |
1,463 |
6,729 |
||
Net sales on a constant currency basis - |
$ 519,938 |
$ 300,107 |
$ 219,831 |
||
Net sales - Three months ended |
$ 505,305 |
$ 284,893 |
$ 220,412 |
||
Net sales growth (decline) on a constant currency basis |
2.9% |
5.3% |
(0.3)% |
||
Hain |
|
International |
|||
Net sales - Twelve months ended 6/30/20 |
$ 2,053,903 |
$ 1,171,478 |
$ 882,425 |
||
Impact of foreign currency exchange |
27,471 |
2,227 |
25,244 |
||
Net sales on a constant currency basis - |
$ 2,081,374 |
$ 1,173,705 |
$ 907,669 |
||
Net sales - Twelve months ended |
$ 2,104,606 |
$ 1,195,979 |
$ 908,627 |
||
Net sales decline on a constant currency basis |
(1.1)% |
(1.9)% |
(0.1)% |
||
Net Sales Growth at Constant Currency and Adjusted for Divestitures and SKU Rationalization |
|||||
Hain |
|
International |
|||
Net sales on a constant currency basis - |
$ 519,938 |
$ 300,107 |
$ 219,831 |
||
Net sales - Three months ended |
$ 505,305 |
$ 284,893 |
$ 220,412 |
||
Divestitures and discontinued brands |
(13,667) |
(13,667) |
- |
||
SKU rationalization |
(6,835) |
(6,335) |
(500) |
||
Net sales on a constant currency basis adjusted for |
$ 484,803 |
$ 264,891 |
$ 219,912 |
||
Net sales growth on a constant currency basis adjusted for |
7.2% |
13.3% |
(0.0)% |
||
Hain |
|
International |
|||
Net sales on a constant currency basis - |
$ 2,081,374 |
$ 1,173,705 |
$ 907,669 |
||
Net sales - Twelve months ended |
$ 2,104,606 |
$ 1,195,979 |
$ 908,627 |
||
Divestitures and discontinued brands |
(32,895) |
(32,895) |
- |
||
SKU rationalization |
(50,257) |
(41,885) |
(8,372) |
||
Net sales on a constant currency basis adjusted for |
$ 2,021,454 |
$ 1,121,199 |
$ 900,255 |
||
Net sales growth on a constant currency basis adjusted for |
3.0% |
4.7% |
0.8% |
||
Adjusted EBITDA Growth at Constant Currency |
|||||
Hain |
|
International |
|||
Adjusted EBITDA - Three months ended 6/30/20 |
$ 62,165 |
$ 43,786 |
$ 29,909 |
||
Impact of foreign currency exchange |
1,214 |
275 |
938 |
||
Adjusted EBITDA on a constant currency basis - |
$ 63,379 |
$ 44,061 |
$ 30,847 |
||
Net sales on a constant currency basis - |
$ 519,938 |
$ 300,107 |
$ 219,831 |
||
Adjusted EBITDA growth on a constant currency basis |
12.2% |
14.7% |
14.0% |
||
Hain |
|
International |
|||
Adjusted EBITDA - Twelve months ended 6/30/20 |
$ 199,993 |
$ 140,886 |
$ 105,696 |
||
Impact of foreign currency exchange |
3,430 |
363 |
3,067 |
||
Adjusted EBITDA on a constant currency basis - |
$ 203,423 |
$ 141,249 |
$ 108,763 |
||
Net sales on a constant currency basis - |
$ 2,081,374 |
$ 1,173,705 |
$ 907,669 |
||
Adjusted EBITDA growth on a constant currency basis |
9.8% |
12.0% |
12.0% |
|
|||
Operating Income (Loss) and Adjusted EBITDA |
|||
Three Months Ended |
|||
(unaudited and in thousands) |
|||
|
|||
|
|
||
Operating income (loss) |
$ 31,867 |
$ (2,745) |
|
Depreciation and amortization |
4,101 |
4,203 |
|
Long-lived asset impairment |
6,196 |
5,617 |
|
Other |
(664) |
(1,062) |
|
Productivity and transformation costs |
1,553 |
3,549 |
|
Loss (gain) on sale of business |
1,448 |
(534) |
|
Warehouse/manufacturing facility start-up costs |
385 |
8,133 |
|
Plant closure related costs |
3 |
126 |
|
SKU rationalization and inventory write-down |
(1,103) |
10,075 |
|
Realized currency loss on repayment of international loans |
- |
2,563 |
|
Adjusted EBITDA |
$ 43,786 |
$ 29,925 |
|
International |
|||
|
|
||
Operating income |
$ 14,667 |
$ 18,112 |
|
Depreciation and amortization |
7,179 |
8,142 |
|
|
394 |
- |
|
Long-lived asset impairment |
4,883 |
4,393 |
|
Other |
21 |
(515) |
|
Productivity and transformation costs |
2,765 |
(913) |
|
Plant closure related costs |
- |
1,058 |
|
SKU rationalization and inventory write-down |
- |
271 |
|
Realized currency loss on repayment of international loans |
- |
105 |
|
Litigation and related expenses |
- |
68 |
|
Adjusted EBITDA |
$ 29,909 |
$ 30,721 |
|
|||
Operating Income (Loss) and Adjusted EBITDA |
|||
Twelve Months Ended |
|||
(unaudited and in thousands) |
|||
|
|||
|
|
||
Operating income |
$ 95,934 |
$ 32,682 |
|
Depreciation and amortization |
16,890 |
16,993 |
|
Long-lived asset impairment |
8,499 |
7,120 |
|
Other |
(486) |
268 |
|
Productivity and transformation costs |
9,053 |
8,333 |
|
SKU rationalization and inventory write-down |
3,996 |
12,111 |
|
Warehouse/manufacturing facility start-up costs |
3,440 |
17,661 |
|
Loss (gain) on sale of business |
3,485 |
(534) |
|
Plant closure related costs |
75 |
1,205 |
|
Realized currency loss on repayment of international loans |
- |
2,563 |
|
Adjusted EBITDA |
$ 140,886 |
$ 98,402 |
|
International |
|||
|
|
||
Operating Income |
$ 55,333 |
$ 58,808 |
|
Depreciation and amortization |
31,437 |
31,515 |
|
|
394 |
- |
|
Long-lived asset impairment |
8,454 |
8,698 |
|
Other |
583 |
(174) |
|
Productivity and transformation costs |
7,034 |
3,186 |
|
Plant closure related costs |
2,282 |
3,467 |
|
SKU rationalization and inventory write-down |
179 |
271 |
|
Realized currency loss on repayment of international loans |
- |
105 |
|
Litigation and related expenses |
- |
87 |
|
Adjusted EBITDA |
$ 105,696 |
$ 105,963 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/hain-celestial-reports-fourth-quarter-and-fiscal-year-2020-financial-results-301117491.html
SOURCE
Katie Turner and Ashley DeSimone, ICR, 646-277-1228